First of all, what is the MyoVision? It’s a static sEMG scanner. It’s very likely that you have a negative point of view on sEMG, as it does have a rather dubious history. I can confidently say, with the support of the VA Hospital, , the MyoVision is not like other sEMG scanners, which are plagued with a history of technical issues. The MyoVision device is a very sensitive, accurate form of electronic palpation; it precisely measures the body’s natural defense mechanism to pain: muscle guarding and splinting. The levels of muscle activity are demonstrated with the length and color of the bars. They are proportional to levels of muscle tension, with arrows pointing in the direction of imbalance. Red readings are high, magenta moderate and yellow are low.  Both low and high readings are important as red indicates very high levels of muscle guarding, and yellow indicates potentially chronic levels of muscle tension.
The MyoVision system is a Class II diagnostic device, which has been used in VA Hospital studies and directly called “the most advanced type of equipment” by researchers at the VA.  It has been tested in control group studies and published in peer reviewed journals, and is the only device of its kind with this distinction. It’s also safer than most regulary used medical devices, like full body scans and X-Ray, where damaging radiation can negatively impact health. The MyoVision scanner is so harmless, it can be used on pregnant women, children and even on those with pacemakers. It is simply a measuring device with no radiation of any kind. 
I, David Marcarian, am the designer of The MyoVision.  It was designed under a National Institutes of Health Grant (NIH) after I completed my research work at NASA. As the designer of the device, I am the first to criticize those using it inappropriately. I have authored the paper, “A proposed quality assurance program for the clinical use Surface Electromyography in the chiropractic office,” published in the Journal of the Canadian Chiropractic Association and am well qualified to discuss the issues associated with public screenings and the use of sEMG technology. Healthcare practitioners who distort the MyoVision data to deceive the public into purchasing care plans not only damages my credibility, but my invention as well. I do not believe misrepresenting science to trick the public into chiropractic care has any benefit to the chiropractic profession. There is a legitimate and valuable application of Surface EMG technology in the screening setting when used properly, and when the results are presented accurately without embellishment. 
I once testified against a chiropractor who claimed the Static sEMG results proved the patient would eventually develop cancer if they were not adjusted. My testimony led to the loss of their license.  

Representing the Insurers: The State of Florida; 300 Insurers, 75 Attorneys, 9 Expert Witnesses and an MD/PhD
Representing the Chiropractic Profession: David Marcarian, MA and Dr. Richard Merritt

The Story:

• The State of Florida determined that MyoVision Motion sEMG lacked validity in evaluating soft tissue injury in auto accident cases, thus removing it from the list of "approved diagnostic devices."
• Richard Merritt, DC, challenged this rule, as he found Motion sEMG invaluable in properly documenting both the need for care & progress with his patients. This challenge was not taken lightly, ending up before an Administrative Law Judge for review.
• Merritt reached out to all the experts on sEMG in the Chiropractic profession to help him in court. To his surprise, only one person responded: David Marcarian, MA, former NASA researcher, former NIH principal investigator and designer of the MyoVision DynaROM Motion sEMG system.
• With the trial date set, a major twist: the State of Florida was to be joined by all the major insurers in the US, represented by 75 attorneys, 9 expert witnesses and millions in funding for this case.
• The insurers knew this tool was gaining momentum in published research as providing proof that chiropractic is the best approach to treating soft tissue injuries, and winning meant establishing soft tissue injury would be difficult.
• Against overwhelming odds, Mr. Marcarian and Dr. Merritt stuck to their guns and battled it out in the courtroom before a judge. Even with the testimony of a well known MD/PhD, Marcarian and Merritt prevailed.

The Decision:

• The Judge's 44 page landmark decision was comprehensive in its scope, leading to reimbursement in every state in the US.
• The case was appealed with Marcarian and Merritt winning the Superior Court appeal. It was then taken to the Supreme Court of Florida, where they were denied an additional appeal. 

This landmark case established this tool equal to the Cardiologist's EKG, providing the proof needed to make you the first choice of PI attorneys when it comes to treating PI Patients.

What this means for you: 

• Overcome the EMC with objective data you send to the MD or DO
• Reimbursement is at approximately $300/test per statute in Florida
• You now dictate care to insurers
• Win the respect of PI attorneys & other healthcare providers alike by providing the objective data needed to establish your expertise